Mountain Valley MD Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: CA62430M1014
CAD
0.07
0.05 (200.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

151.15 k

Shareholding (Aug 2017)

FII

0.00%

Held by 0 FIIs

DII

100.00%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

CAD 28 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.23

stock-summary
Return on Equity

-286.50%

stock-summary
Price to Book

28.19

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2026)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
200.0%
0%
200.0%
6 Months
200.0%
0%
200.0%
1 Year
66.67%
0%
66.67%
2 Years
50.0%
0%
50.0%
3 Years
-16.67%
0%
-16.67%
4 Years
-87.5%
0%
-87.5%
5 Years
15.38%
0%
15.38%

Mountain Valley MD Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
1.17%
EBIT Growth (5y)
2.57%
EBIT to Interest (avg)
-4.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
28.19
EV to EBIT
-9.95
EV to EBITDA
-10.41
EV to Capital Employed
27.96
EV to Sales
27.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-281.00%
ROE (Latest)
-286.50%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Aug 2017stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 86.27% vs -200.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.60",
          "val2": "-1.10",
          "chgp": "45.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-4.00",
          "chgp": "97.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.70",
          "val2": "-5.10",
          "chgp": "86.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-24,461.50%",
          "val2": "-61,777.80%",
          "chgp": "3,731.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 62.67% vs 2.60% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.30",
          "val2": "-3.40",
          "chgp": "32.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "-3.90",
          "chgp": "89.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.80",
          "val2": "-7.50",
          "chgp": "62.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-35,907.70%",
          "val2": "-75,061.20%",
          "chgp": "3,915.35%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.60
-1.10
45.45%
Interest
0.00
0.00
Exceptional Items
-0.10
-4.00
97.50%
Consolidate Net Profit
-0.70
-5.10
86.27%
Operating Profit Margin (Excl OI)
-24,461.50%
-61,777.80%
3,731.63%
USD in Million.
Net Sales

YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 86.27% vs -200.00% in Mar 2025

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
0.10
0.00
Operating Profit (PBDIT) excl Other Income
-2.30
-3.40
32.35%
Interest
0.00
0.00
Exceptional Items
-0.40
-3.90
89.74%
Consolidate Net Profit
-2.80
-7.50
62.67%
Operating Profit Margin (Excl OI)
-35,907.70%
-75,061.20%
3,915.35%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 62.67% vs 2.60% in Mar 2025

stock-summaryCompany CV
About Mountain Valley MD Holdings, Inc. stock-summary
stock-summary
Mountain Valley MD Holdings, Inc.
Other Agricultural Products
Mountain Valley MD Holdings Inc, formerly Meadow Bay Gold Corporation (Meadow Bay), is a Canada-based company. Through its subsidiary, Mountain Valley MD Inc., the Company is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine and pharmaceutical drug applications. Its Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into product formats that are consumed orally. The resulted product formulations are capable of delivering vaccines, drugs and nutraceuticals into the body faster.
Company Coordinates stock-summary
Company Details
610 - 475 West Georgia Street , VANCOUVER BC : V6B 4M9
stock-summary
Tel: 1 604 64144501 613 8827467
stock-summary
Registrar Details